Variability in body temperature in healthy adults and in patients receiving chemotherapy: prospective observational cohort study

被引:3
|
作者
Frazer J.S. [1 ]
Barnes G.E. [1 ]
Woodcock V. [2 ]
Flanagan E. [2 ]
Littlewood T. [1 ,2 ]
Stevens R.J. [3 ]
Fleming S. [3 ]
Ashdown H.F. [3 ]
机构
[1] Medical School, University of Oxford, Oxford
[2] Oxford Cancer and Haematology Centre, Churchill Hospital, Oxford University Hospitals NHS Trust, Oxford
[3] Nuffield Department of Primary Care Health Sciences, University of Oxford, Oxford
来源
关键词
chemotherapy; neutropenic sepsis; Temperature variability; thermometry;
D O I
10.1080/03091902.2019.1667446
中图分类号
学科分类号
摘要
Between-individual variability of body temperature has been little investigated, but is of clinical importance: for example, in detection of neutropenic sepsis during chemotherapy. We studied within-person and between-person variability in temperature in healthy adults and those receiving chemotherapy using a prospective observational design involving 29 healthy participants and 23 patients undergoing chemotherapy. Primary outcome was oral temperature. We calculated each patient’s mean temperature, standard deviation within each patient (within-person variability), and between patients (between-person variability). Secondary analysis explored temperature changes in the three days before admission for neutropenic sepsis. 1,755 temperature readings were returned by healthy participants and 1,765 by chemotherapy patients. Mean participant temperature was 36.16 C (95% CI 36.07–36.26) in healthy participants and 36.32 C (95% CI 36.18–36.46) in chemotherapy patients. Healthy participant within-person variability was 0.40 C (95% CI 0.36–0.44) and between-person variability was 0.26 C (95% CI 0.16–0.35). Chemotherapy patient within-person variability was 0.39 C (95% CI 0.34–0.44) and between-person variability was 0.34 C (95% CI 0.26–0.48). Thus, use of a population mean rather than personalised baselines is probably sufficient for most clinical purposes as between-person variability is not large compared to within-person variability. Standardised guidance and provision of thermometers to patients might help to improve recording and guide management. © 2019, © 2019 Informa UK Limited, trading as Taylor & Francis Group.
引用
收藏
页码:323 / 333
页数:10
相关论文
共 50 条
  • [1] Neutropenic complications in ovarian cancer patients receiving chemotherapy: Results of a prospective observational study
    Myer, B. S.
    Cosler, L. E.
    Crawford, J.
    Dale, D. C.
    Selby, C.
    Wolff, D. A.
    Poniewierski, M. S.
    Culakova, E.
    Lyman, G. H.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [2] Venous thromboembolismin hospitalized cancer patients receiving chemotherapy in Japan: a prospective observational study
    Kitayama, Hiromitsu
    Tsuji, Yasushi
    Sugiyama, Junko
    Kondo, Tomohiro
    Hirayama, Michiaki
    ANNALS OF ONCOLOGY, 2015, 26 : 81 - 81
  • [3] Frailty in older adults patients: a prospective observational cohort study on subtype identification
    Zhikai Yang
    Chen Ji
    Ting Wang
    Wei He
    Yuhao Wan
    Min Zeng
    Di Guo
    Lingling Cui
    Hua Wang
    European Journal of Medical Research, 30 (1)
  • [4] Safety and efficacy of apixaban as thromboprophylaxis in myeloma patients receiving chemotherapy: A prospective cohort study
    Sayar, Zara
    Gates, Carolyn
    Bristogiannis, Sotirios
    Patel, Aisha
    Ogunbiyi, Margaret Olabisi
    Tailor, Anish
    Yong, Kwee
    Thomas, Mari
    THROMBOSIS RESEARCH, 2022, 213 : 27 - 29
  • [5] Lymphoproliferative disorders in patients receiving thiopurines for inflammatory bowel disease: a prospective observational cohort study
    Beaugerie, Laurent
    Brousse, Nicole
    Bouvier, Anne Marie
    Colombel, Jean Frederic
    Lemann, Marc
    Cosnes, Jacques
    Hebuterne, Xavier
    Cortot, Antoine
    Bouhnik, Yoram
    Gendre, Jean Pierre
    Simon, Tabassome
    Maynadie, Marc
    Hermine, Olivier
    Faivre, Jean
    Carrat, Fabrice
    LANCET, 2009, 374 (9701): : 1617 - 1625
  • [6] Safety and Efficacy of Apixaban as Thromboprophylaxis in Multiple Myeloma Patients Receiving Chemotherapy: A Prospective Cohort Study
    Sayar, Zara
    Gates, Carolyn
    Bristogiannis, Sotirios
    Patel, Aisha
    Ogunbiyi, Margaret
    Tailor, Anish
    Yong, Kwee
    Thomas, Mari
    BRITISH JOURNAL OF HAEMATOLOGY, 2022, 197 : 147 - 148
  • [7] Safety and efficacy of apixaban as thromboprophylaxis in multiple myeloma patients receiving chemotherapy: a prospective cohort study
    Sayar, Z.
    Gates, C.
    Bristogiannis, S.
    Patel, A.
    Ogunbiyi, M. O.
    Tailor, A.
    Yong, K.
    Thomas, M.
    THROMBOSIS RESEARCH, 2022, 213 : S6 - S7
  • [8] A Multicenter, Prospective, Observational Study to Evaluate Ethanol-Induced Symptoms in Patients Receiving Docetaxel Chemotherapy
    Won, Young-Woong
    Kang, Jin-Hyoung
    Kwon, Jung Hye
    Koo, Dong-Hoe
    Kang, Jung Hun
    Maeng, Chi Hoon
    Ahn, Hee Kyung
    Oh, Sung Yong
    Lee, Dae-Won
    Sohn, Joohyuk
    Oh, So Yeon
    Lee, Kyung Hee
    Koh, Su-Jin
    Lee, Keun Seok
    Kim, Chan-Kyu
    Kim, Ji-Yeon
    Ji, Jun Ho
    Kim, Sung-Bae
    Ha, Joo Young
    Kim, Ho Young
    CANCER RESEARCH AND TREATMENT, 2023, 55 (04): : 1096 - 1103
  • [9] Invasive fungal infection in patients receiving chemotherapy for hematological malignancy: a multicenter, prospective, observational study in China
    Sun, Yuqian
    Huang, He
    Chen, Jing
    Li, Jianyong
    Ma, Jun
    Li, Juan
    Liang, Yingmin
    Wang, Jianmin
    Li, Yan
    Yu, Kang
    Hu, Jianda
    Jin, Jie
    Wang, Chun
    Wu, Depei
    Xiao, Yang
    Huang, Xiaojun
    TUMOR BIOLOGY, 2015, 36 (02) : 757 - 767
  • [10] Venous thromboembolism in hospitalized patients receiving chemotherapy for malignancies at Japanese community hospital: prospective observational study
    Kitayama, Hiromitsu
    Kondo, Tomohiro
    Sugiyama, Junko
    Kurimoto, Kazutomo
    Nishino, Yasuhiro
    Hirayama, Michiaki
    Tsuji, Yasushi
    BMC CANCER, 2017, 17